By Staff Reporters
***
***
Executives at GSK Plc (NYSE: GSK), Moderna Inc (NASDAQ: MRNA), and CSL Seqirus, owned by CSL (OTC: CSLLY), said they are developing or about to test sample human vaccines against bird flu as a precautionary measure against a future pandemic. Others, like Sanofi SA (NASDAQ: SNY), “stand ready” to begin production if needed, with existing H5N1 vaccine strains in stock. The U.N. said it had signed legally binding agreements with 14 manufacturers for 10% of their pandemic flu vaccine in a mix of donated doses and doses to be bought at affordable prices.
Health Insurance: https://www.amazon.com/Dictionary-Health-Insurance-Managed-Care/dp/0826149944/ref=sr_1_4?ie=UTF8&s=books&qid=1275315485&sr=1-4
***
Shares in troubled First Republic Bank crashed more than 46% on Monday, after reports the San Francisco-based bank may need to raise more funds despite a $30bn (£24bn) rescue last week.
***
U.S. stocks ended the day higher, as the financials sector bounced back amid the recent choppiness in the markets. Meanwhile, uncertainty remained regarding whether the turmoil will impact the Fed’s monetary policy decision on Wednesday. Banking stocks continued to be in focus, as UBS Group agreed to acquire Credit Suisse for a little over $3.0 billion, while the Fed and five other major central banks took action to increase the availability of liquidity for the financial system.
Treasury yields were higher, and the U.S. dollar was lower, while crude oil and gold prices gained ground.
Asia finished broadly lower, and markets in Europe rose sharply, as investors around the world contend with the latest updates surrounding global banks.
***
***
COMMENTS APPRECIATED
Thank You
***
Filed under: Alerts Sign-Up, Drugs and Pharma, Ethics, Health Insurance, Health Law & Policy, Healthcare Finance, Research & Development, Risk Management | Tagged: Asian stocks, bank stocks, banks, bird flu, bird flu vaccine, Credit Suisse, CSL, European stocks, First Republic Bank, FRB, GSK, H5N1, Moderna, Sanofi, Treasury yields, UBS, UN | Leave a comment »